188 related articles for article (PubMed ID: 34791797)
21. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
[TBL] [Abstract][Full Text] [Related]
22. Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjögren's syndrome.
Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
PLoS One; 2021; 16(10):e0258428. PubMed ID: 34624052
[TBL] [Abstract][Full Text] [Related]
23. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
25. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjögren's syndrome.
Lee KA; Lee SH; Kim HR
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):165-172. PubMed ID: 29600950
[TBL] [Abstract][Full Text] [Related]
27. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome.
Le Goff M; Cornec D; Jousse-Joulin S; Guellec D; Costa S; Marhadour T; Le Berre R; Genestet S; Cochener B; Boisrame-Gastrin S; Renaudineau Y; Pers JO; Saraux A; Devauchelle-Pensec V
Arthritis Res Ther; 2017 Dec; 19(1):269. PubMed ID: 29208023
[TBL] [Abstract][Full Text] [Related]
29. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
30. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
31. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
Maślińska M; Mańczak M; Kwiatkowska B; Ramsperger V; Shen L; Suresh L
Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
[TBL] [Abstract][Full Text] [Related]
32. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
34. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome.
Wei P; Li C; Qiang L; He J; Li Z; Hua H
Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e156-60. PubMed ID: 25475778
[TBL] [Abstract][Full Text] [Related]
35. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
36. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
[TBL] [Abstract][Full Text] [Related]
37. Proteomics of saliva, plasma, and salivary gland tissue in Sjögren's syndrome and non-Sjögren patients identify novel biomarker candidates.
Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
J Proteomics; 2020 Aug; 225():103877. PubMed ID: 32540407
[TBL] [Abstract][Full Text] [Related]
38. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
[TBL] [Abstract][Full Text] [Related]
39. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody synthesis in salivary glands of Sjögren's syndrome patients.
Horsfall AC; Rose LM; Maini RN
J Autoimmun; 1989 Aug; 2(4):559-68. PubMed ID: 2789658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]